These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 11564647)
1. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. Szabo B; Fritz T; Wedzony K Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine. Bock C; Niederhoffer N; Szabo B Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine. Szabo B; Bock C; Nordheim U; Niederhoffer N Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923 [TBL] [Abstract][Full Text] [Related]
4. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine. Szabo B; Urban R Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413 [TBL] [Abstract][Full Text] [Related]
5. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine. Chan CK; Head GA J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of sympathoinhibition by imidazolines. Szabo B; Urban R Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits. Godwin SJ; Tortelli CF; Parkin ML; Head GA J Auton Nerv Syst; 1998 Oct; 72(2-3):195-204. PubMed ID: 9851569 [TBL] [Abstract][Full Text] [Related]
8. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. Chan CK; Sannajust F; Head GA J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304 [TBL] [Abstract][Full Text] [Related]
9. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats. Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761 [TBL] [Abstract][Full Text] [Related]
10. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Urban R; Szabo B; Starke K Eur J Pharmacol; 1995 Aug; 282(1-3):29-37. PubMed ID: 7498287 [TBL] [Abstract][Full Text] [Related]
11. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents. Head GA Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926 [TBL] [Abstract][Full Text] [Related]
12. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine. Chan CK; Burke SL; Head GA J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186 [TBL] [Abstract][Full Text] [Related]
13. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents. Head GA Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of clonidine-like drugs in pithed rabbits. Pompermayer K; Salgado MC; Feldman J; Bousquet P Hypertension; 1999 Oct; 34(4 Pt 2):1012-5. PubMed ID: 10523400 [TBL] [Abstract][Full Text] [Related]
15. No evidence for functional imidazoline receptors on locus coeruleus neurons. Szabo B; Fröhlich R; Illes P Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice. Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548 [TBL] [Abstract][Full Text] [Related]
17. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits. Parkin ML; Godwin SJ; Head GA J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats. Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708 [TBL] [Abstract][Full Text] [Related]
19. Site and receptors involved in the sympathoinhibitory actions of rilmenidine. Head GA; Burke SL; Chan CK J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904 [TBL] [Abstract][Full Text] [Related]
20. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Armah BI; Hofferber E; Stenzel W Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]